SCHEMBL3080077

SCHEMBL3080077

O=C(O)C=Cc1ccc(-c2ccc(C(=O)C(F)(F)F)s2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 17/20 0.64
HDAC1 Q13547 10/20 0.63
HDAC4 P56524 8/20 0.49
HDAC3 O15379 2/20 0.46
CA12 O43570 1/20 0.42
AKR1B10 O60218 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
ESR1 P03372 1/20 0.42
CA3 P07451 1/20 0.42
PKM P14618 1/20 0.42
TYR P14679 1/20 0.42
AKR1B1 P15121 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
DPP4 P27487 1/20 0.42
CA5A P35218 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
HCAR2 Q8TDS4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3080076 1.00 HDAC6 (0.64) HDAC6HDAC1HDAC4HDAC3CA12
SCHEMBL3089445 0.88 HDAC6 (0.68) HDAC6HDAC1HDAC4HDAC3
SCHEMBL3089442 0.88 HDAC6 (0.68) HDAC6HDAC1HDAC4HDAC3
SCHEMBL3094688 0.79 HDAC6 (1.00) HDAC6HDAC1HDAC4HDAC3MEN1
SCHEMBL3080088 0.78 HDAC6 (1.00) HDAC6HDAC1HDAC4HDAC3MEN1
SCHEMBL3081838 0.77 HPGD (0.47) HDAC6HDAC1HDAC4HDAC3PKM
SCHEMBL3081835 0.77 HPGD (0.47) HDAC6HDAC1HDAC4HDAC3PKM
SCHEMBL3088708 0.76 HDAC6 (0.71) HDAC6HDAC1HDAC4HDAC3
SCHEMBL3098329 0.74 HDAC6 (0.77) HDAC6HDAC1HDAC4HDAC3MEN1
SCHEMBL3091022 0.74 HDAC6 (0.68) HDAC6HDAC1HDAC4HDAC3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1987024-B1 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS MSD ITALIA SRL (IT) 2016-10-19 EP disclosed
US-7799825-B2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2010-09-21 US disclosed
US-20090076101-A1 Thiophene and Thiazole Substituted Trifluoroethanone Derivatives as Histone Deacetylase (HDAC) Inhibitors MSD ITALIA S.R.L. (IT) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076101-A1 Thiophene and Thiazole Substituted Trifluoroethanone Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC1, HDAC4, HDAC7 HDAC6 10/4885HDAC1 1/4885HDAC4 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.